Aptus Pharma Ltd

BSE: 544529 · Pharmaceuticals & Biotechnology · 3 announcements

Share price: ₹347.00
Market cap: ₹595.1 Cr
Revenue (annual): ₹46.57 Cr
Net profit (annual): ₹4.62 Cr
P/E (TTM): 128.8×Sector 50.4×
Promoter holding: 72.89%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1 Earnings Call 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 May 2026 16:47 IST BSE

Earnings Call

Aptus Pharma Earnings Call: Key Takeaways

Aptus Pharma (BSE SME) reports strong growth in FY26 following its 2025 listing. The company operates an asset-light, marketing-focused model with 250+ formulations across diverse therapeutic segments.

Open call summary → Read the filing ↗